Serum Ferritin in Haemodialysis Patients: Role of Blood Transfusions and Haemochromatosis Alleles’ HLA A3, B7 and B14
- 1 January 1984
- journal article
- research article
- Published by S. Karger AG in Nephron
- Vol. 36 (2) , 106-110
- https://doi.org/10.1159/000183127
Abstract
In 48 patients on maintenance haemodialysis (HD), serum ferritin (SF) levels were measured and compared with ‘haemochromatosis alleles’, (HA), HLA A3, B7 and B14. A positive correlation was found between high SF levels and the presence of HA. When patients who had received 10 or fewer blood transfusions were studied, it was observed that this correlation did not exist, but it was evident, however, in patients who had received more than 10 blood transfusions. After 14 months in which blood transfusions were restricted, no significant difference in SF was observed between HA carriers and the rest. Our findings suggest that repeated blood transfusions can cause high SF in HD patients, especially in those with HLA A3, B7 or B14 antigens. Among our patients, restriction of blood transfusions seems sufficient to decrease high SF levels.Keywords
This publication has 5 references indexed in Scilit:
- FAILURE OF SERUM FERRITIN LEVELS TO PREDICT BONE-MARROW IRON CONTENT AFTER INTRAVENOUS IRON-DEXTRAN THERAPYThe Lancet, 1982
- IRON-METABOLISM IN HEMODIALYSIS-PATIENTS - STUDY OF THE MANAGEMENT OF IRON THERAPY AND OVERLOAD1979
- IDIOPATHIC HEMOCHROMATOSIS LINKAGE WITH HLA SYSTEM1978
- Hemosiderosis Secondary to Chronic Parenteral Iron Therapy in Maintenance Hemodialysis PatientsNephron, 1978
- Iron Balance in Hemodialysis PatientsAnnals of Internal Medicine, 1977